This inventor holds 1 USPTO granted patent. Top assignee: Hubei Zhangjun Biotech Co.,ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Chenglin Deng - Innovator in Flavivirus Research
Introduction
Chenglin Deng is an inventor based in Wuhan, China. He has made significant contributions to the field of virology, particularly in the development of attenuated viruses for vaccine applications. His innovative approach focuses on enhancing the safety and efficacy of vaccines derived from flavivirus viruses.
Latest Patent Applications
Chenglin Deng has submitted a patent application titled "Attenuated Virus of Flavivirus Virus and Use Thereof." This application describes an attenuated virus that includes a polyadenylic acid (poly(A)) sequence. The poly(A) sequence replaces a portion of the nucleotide sequence in the 3′ untranslated region (3′UTR) of the flavivirus virus. The resulting attenuated virus retains a 3′-end stem loop region (3′SL), which is crucial for its functionality. This innovation aims to prepare safe and effective attenuated vaccine strains.
Conclusion
Chenglin Deng's work in developing attenuated viruses represents a promising advancement in vaccine technology. His research could lead to safer and more effective vaccines for combating flavivirus-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile